Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The conversation discusses Scube3, a seemingly new and obscure treatment for hair loss, with limited information available and a link to a patient intake form.

There is an inconsistency between the molecular weight and formula listed on EveryChem's product page and the analytical PDFs for 3HP and PP30, suggesting a possible error in the product description. Concerns are raised about EveryChem's business practices and lack of transparency in testing and manufacturing.

PP405 now has a Wikipedia page, generating more discussion and attention. One user plans to continue using finasteride until PP405 is proven effective and widely available.

People are hopeful for a permanent hair loss solution by the 2030s, considering options like hair cloning and treatments like pp405. Synthetic hair transplants have been attempted but are not effective long-term.

An Instagram page is stealing hair loss progress pictures to advertise a scam product. Users suggest watermarking images and reporting the account.

Kintor edited their Amazon page, removing claims that KX-826 provides "real" visible results from clinical experiments. The discussion includes treatments like Minoxidil, finasteride, and RU58841.

The conversation discusses hair loss treatments, specifically Minoxidil, finasteride, and RU58841. It also mentions observations about the Amla page on Examine.

A user shared their positive experience with hair loss treatments, using 1.25mg finasteride, alternating oral and topical minoxidil, and weekly microneedling with a 1mm dermaroller. They reported significant improvement in their hairline and regained confidence.

A 28-year-old male stopped hair loss and thickened his hair using oral dutasteride and oral minoxidil after topical treatments failed. He experienced no side effects and recommends these oral treatments for others struggling with hair loss.

A Phase 1 update for the HMI 115 clinical trial, which involves 16 participants and is expected to end in July 2023; as well as changes to the recruitment process, including treatment protocols with Minoxidil, Finasteride, and RU58841.

Treatments for hair loss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.

The conversation discusses the application frequency of a 1% Koshine solution for hair loss, with recommendations varying between once or twice daily. It is noted that the 1% solution is more effective than the 0.5% solution.

Kintor is accused of using fake pictures to promote their product, Pyrilutamide (KX826), which failed Phase 3 trials. Users express disappointment and note similar false advertising has occurred with finasteride and minoxidil.

A 36-year-old started using 0.5mg finasteride and 2.5mg oral minoxidil daily for hair loss, reporting positive results without side effects. Despite criticism about photo lighting, the user remains optimistic about continued improvement.

Pelage Pharmaceuticals is starting Phase 3 trials for PP405 in September 2026, with potential market release by 2030. Users discuss various hair loss treatments like minoxidil, finasteride, RU58841, kx, breezula, and gt20029, expressing hope for future hair restoration.

Minoxidil, finasteride, and RU58841 are discussed as hair loss treatments. User skepticism is expressed about the effectiveness of these treatments.

A 34-year-old man shared his one-year hair regrowth progress using topical minoxidil, oral finasteride, and multivitamins, experiencing low libido as a side effect of finasteride. He plans to continue the treatment for life, noting significant results after nine months.

The user is using RU58841, Minoxidil, and weekly microneedling for hair loss, having stopped finasteride due to side effects like low libido and depression. They are considering dutasteride as an alternative but are cautious due to past experiences with DHT blockers.

The conversation discusses the potential updates on the pp405 trial for hair loss, with completion expected by December 2025. Participants express skepticism about new treatments, suggesting continued use of finasteride, while others hope for innovative solutions beyond current medications.

A person experienced hair loss after switching from finasteride to dutasteride and returned to finasteride, adding oral minoxidil. Dutasteride may increase scalp testosterone, worsening hair loss for some individuals.

The study on creatine monohydrate's effect on hair loss was withdrawn due to lack of support. Users discussed concerns about creatine potentially accelerating hair loss, especially for those using finasteride.

The user is considering switching from topical finasteride to RU58841 or KX826 to reduce side effects but decides to stick with finasteride for now. Users discuss the effectiveness and risks of RU58841 and KX826, with finasteride being considered the most reliable option.

Nemanja Gudelj likely uses finasteride and minoxidil alongside his hair transplant. Many believe medication is necessary for maintaining hair transplant results, though some claim success without it.

He Shou Wu (fo-ti) is discussed as a potential treatment for hair regrowth, with mixed opinions on its effectiveness. Some users report positive results, while others remain skeptical or have not noticed any changes.

The user experienced hair regrowth using oral Dutasteride and Minoxidil over 6-7 months, despite some ongoing hair shedding. They reported no significant side effects, although some users discussed potential brain fog and cognitive issues possibly linked to Dutasteride.

A 20-year-old is using finasteride, minoxidil, biotin supplements, and ketoconazole shampoo for hair loss but is disheartened by the lack of progress. A user suggests using fewer treatments and being cautious with ketoconazole in winter.

Creatine may increase DHT levels, potentially affecting hair loss in some individuals, but opinions vary. Some users report hair loss while on creatine, while others see no effect, especially when using treatments like finasteride, minoxidil, and microneedling.

OrganTech is working on regenerating hair and teeth, with positive results in mice, but skepticism remains about progress for humans. Users express frustration over the lack of advancements in human hair loss treatments, despite ongoing research and trials.

The conversation discusses using Dr. Bronner's unscented soap as a potential shampoo and the benefits of adding rosemary oil. One user suggests applying rosemary oil to the scalp before washing.